Health·El País·22h agoSpain
Novartis Spain: Drug Access Takes 537 Days
Executive urges faster patient access to approved drugs
Negative1 min readImportance
AI Summary
Novartis Spain president Amaya Echevarría told the Foro CREO that Spanish patients wait an average of 537 days for drug access, versus Europe's 600 and the EU target of 180.
Keywords
NovartisSpaindrug accesspharmaceutical innovationhealthcare policy
